Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa
Affiliations
- PMID: 2467637
Item in Clipboard
Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa
Arch Immunol Ther Exp (Warsz).
1988.
Abstract
Monovalent immune sera against somatic antigens (anti-O) have been shown to potentiate phagocytosis exclusively of nonmucoid homologous immunotypes. To obtain polyvalent immunity for all nonmucoid immunotypes of P. aeruginosa, all immunotypes of these bacteria have to be used for immunization.
Similar articles
-
Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.Arch Immunol Ther Exp (Warsz). 1988;36(2):195-203. Arch Immunol Ther Exp (Warsz). 1988. PMID: 3149178
-
Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.Arch Immunol Ther Exp (Warsz). 1988;36(2):185-93. Arch Immunol Ther Exp (Warsz). 1988. PMID: 3149177
-
Evaluation of polyvalent anti-Pseudomonas aeruginosa vaccine in phagocytic reaction.Arch Immunol Ther Exp (Warsz). 1990;38(3-4):291-7. Arch Immunol Ther Exp (Warsz). 1990. PMID: 2129384
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
-
Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.Expert Rev Vaccines. 2005 Oct;4(5):645-56. doi: 10.1586/14760584.4.5.645. Expert Rev Vaccines. 2005. PMID: 16221066 Review.